| Applications: |
Immunodepletion/Immunocompetition |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
CXCR3 Blocking Peptide for STJ500658 is synthetically produced from the 20-70 sequence and is suitable for use in western blot applications. |
| Formulation: |
Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction: |
Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Immunogen Region: |
20-70 |
| Specificity: |
This blocking peptide is recommended for use in combination with CXCR3 antibody, STJ500658 |
| Immunogen: |
Synthetic peptide taken within amino acid region 20-70 on rat CXCR3 protein |
| Background | Receptor for C-X-C chemokines: CXCL9, CXCCl10 and CXCL11, mediates the proliferation, survival and angiogenic activity of mesangial cells via a heterotrimeric G-protein signalling pathway |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
